Gynuity Health Projects   Report issue

Foundation Phase 1 Phase 2 Phase 4
Founded: New York NY United States (2003)

Organization Overview

First Clinical Trial
2004
NCT00670761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Gynuity Health Projects

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Incomplete (Phase 1)

Abortion, Missed (Phase 4)

Death (Phase 3)

Eclampsia (Phase 3)

Fetal Death (Phase 3)

Hemorrhage (Phase 4)

Hypertension (Phase 4)

Hypertension, Pregnancy-Induced (Phase 4)

Postpartum Hemorrhage (Phase 4)

Pre-Eclampsia (Phase 4)

Stillbirth (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 71
  • # of Trial APIs: 12